HMGA2 is associated with epithelial–mesenchymal transition and can predict poor prognosis in nasopharyngeal carcinoma
OncoTargets and Therapy2015Vol. 8, pp. 169–169
Citations Over TimeTop 17% of 2015 papers
Youyou Xia, Xia He, Yin Li, Hao Tian, Xu‐Guang Guo, Ning Jiang, Xuesong Jiang, Jing Wu, Meng Chen, Jian Wu
Abstract
These results demonstrated that HMGA2, an independent prognostic factor, may promote NPC progression and metastasis, and is significantly associated with EMT proteins. Therefore, HMGA2 may be considered a potential therapeutic target in NPC.
Related Papers
- Quantitative detection of epstein-Barr virus infectious status in nasopharyngeal carcinoma tissues(2010)
- Correlation between Epstern-Barr virus andangiogenesis of patients with nasopharyngeal carcinoma(2011)
- Value Analysis of Plasma Epstein-barr Virus DNA Concentration Detection in Screening and Clinical Staging Diagnosis of Nasopharyngeal Carcinoma(2020)
- → Data from Multiparametric Detection of Antibodies against Different EBV Antigens to Predict Risk for Nasopharyngeal Carcinoma in a High-Risk Population of China(2023)
- → Data from Multiparametric Detection of Antibodies against Different EBV Antigens to Predict Risk for Nasopharyngeal Carcinoma in a High-Risk Population of China(2023)